Gene Query: VSNL1

Dataset Description Geneva Score
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 134.72
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 104.25
Alteration of the microRNA network during the progression of Alzheimer’s disease 53.43
RNA sequencing of BT142 and TS603 cell lines 51.09
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 51.09
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 50.15
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 50.15
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 49.78
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 48.52
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 46.6
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 44.3
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 43.03
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 40.03
DIGIT regulates endoderm differentiation of human embryonic stem cells 36.14
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 34.99
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 34.58
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 34.4
Global expression profiles in cardiac progenitor cells generated by ISX-9 34.4
Differentially expressed genes post knock down of lincDUSP26 34.37
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 33.57
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 33.06
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 27.28
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 26.67
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 26.05
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 25.98
The Glioma-Infiltrating T Cell Receptor Repertoire 25.94
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 25.23
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 24.77
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 24.21
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 23.78
RNA sequencing analysis of selumetinib-resistant CRC cells lines 22.89
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 21.33
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 21.18
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 21.18
WRN knockout effects upon gene expression in SW48 and OVK18 20.61
circRNA-sequencing 20.49
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 18.78
Hepatitis C virus functionally sequesters miR-122 18.59
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 18.59
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 18.13
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 18.13
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 17.59
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 17.01
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 16.84
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 16.35
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 15.99
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 15.96
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 15.67
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 15.44
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 15.44
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 14.78
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 14.75
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 14.66
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 14.63
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 14.47
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 14.23
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 14.04
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 14.04
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 14.0
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 13.84
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 13.72
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 13.62
Human embryonic stem cells in E8 and AKIT culture medium 13.62
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 13.58
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 13.48
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 13.24
RNA-Seq from early time points in the kidney differentiation protocol 13.12
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 13.09
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 13.09
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 13.04
Maturation of human iNSCs 13.03
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 13.02
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 13.02
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 12.89
RNA-Seq of the corpus callosum from 12 individuals 12.6
Repurposing of promoters and enhancers during mammalian evolution 12.5
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 12.46
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 12.4
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 12.19
RNA-Sequencing of HepG2 cells treated with TGFBeta 12.04
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 11.66
RNA-seq analysis of RALD iPSCs after in vitro differentiation 11.58
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 11.58
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 11.57
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 11.38
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 11.35
RNA-sequencing in immortalized human mammary epithelial cells 11.3
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 11.3
RNA-seq of YB5 cells treated with Proscillaridin A 11.12
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 11.0
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 10.8
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 10.71
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 10.67
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 10.5
RNA sequencing analysis of human embryonic stem cells and axial progenitors 10.44
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 10.31
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 10.31
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 10.29
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 10.22
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 10.11
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 10.08
Ectoderm specification of H1 human embryonic stem cells 10.0
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 9.96
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 9.89
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 9.89
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 9.84
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 9.84
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 9.54
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 9.49
Oncogenic MYC induces a dependency on the spliceosome in human cancer 9.46
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 9.42
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 9.33
Universal alternative splicing of noncoding exons 9.27
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 9.12
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 8.79
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 8.32
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 8.25
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 8.25
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 8.21
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 8.21
Gene expression analysis of dengue-infected cells 8.14
Transcriptomic and gene ontology profiling of the human corneal cell types 8.05
RNA-seq in HepG2 and IMR90 cells 7.92
Evolution of a transcriptional regulator from a transmembrane nucleoporin 7.92
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 7.9
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 7.86
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 7.86
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 7.84
Postnatal lipids drive hepatocyte maturation 7.32
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 7.15
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 7.07
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 7.05
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 7.03
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 7.02
Differentially expressed vascular development genes for iPSC-ECs from CDI 7.01
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 7.01
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 6.99
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 6.99
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 6.96
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 6.87
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 6.87
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 6.81
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 6.8
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 6.8
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 6.73
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 6.7
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 6.7
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 6.58
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 6.48
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 6.48
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 6.46
BI Human Reference Epigenome Mapping Project 6.42
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 6.38
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 6.33
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 6.33
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 6.21
High-efficiency RNA-based reprogramming of human primary fibroblasts 6.17
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 6.13
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 6.11
An optimization system for isolating and sequencing of single human colon cancer cells 6.07
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 6.06
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 6.06
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 5.94
Gene expressions of H9s in different culture systems 5.91
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 5.89
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 5.88
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 5.86
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 5.8
Single-nucleotide-resolution mapping of HBV promoters using CAGE 5.74
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 5.65
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 5.65
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 5.62
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 5.59
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 5.59
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 5.57
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 5.51
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 5.44
Dynamic reorganization of nuclear architecture during human cardiogenesis 5.42
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 5.42
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 5.4
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 5.4
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 5.4
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 5.4
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 5.3
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 5.26
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 5.18
Global analyses of the effect of different cellular contexts on microRNA targeting 5.18
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 5.18
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 5.17
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 5.16
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 5.14
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 5.0
Identifying the molecular mode of action of itraconazole in colorectal cancer 4.99
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 4.92
Gene Expression Profiling of WT and KDM3A Knocked out Cell 4.92
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 4.76
An RNA-centric dissection of host complexes controlling flavivirus infection 4.56
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 4.56
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 4.51
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 4.47
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 4.45
MEIS1 regulates hematopoiesis in hPSCs 4.43
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 4.41
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 4.4
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 4.37
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 4.26
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 4.17
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 4.17
Transposon-based construction of strand-specific RNA-seq libraries 4.16
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 4.08
Lineage specific differentiation is influenced by state of human pluripotency 4.08
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 4.08
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 4.05
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 3.99
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 3.99
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 3.97
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 3.97
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 3.97
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 3.96
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 3.94
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 3.94
Entrectinib Resistance in a Neuroblastoma Xenograft Model 3.9
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 3.89
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 3.88
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 3.82
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 3.79
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 3.7
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 3.7
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 3.69
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 3.68
nELAVL HITS-CLIP in Alzheimer's Disease patients 3.66
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 3.64
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 3.64
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 3.63
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 3.63
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 3.59
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 3.57
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 3.54
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 3.53
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 3.53
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 3.52
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 3.47
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 3.42
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 3.42
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 3.42
Transcriptional profiling of microglia; current state of the art and future perspectives 3.42
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 3.38
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 3.38
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 3.37
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 3.37
Transcriptional landscape changes during human embryonic stem cell derivation 3.33
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 3.31
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 3.31
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 3.3
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 3.29
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 3.27
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 3.26
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 3.23
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 3.23
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 3.21
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 3.2
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 3.2
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 3.16
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 3.09
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 3.09
p63 controls the enhancer landscape during keratinocyte differentiation 3.06
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 3.0
Integrin signaling regulates YAP/TAZ to control skin homeostasis 2.95
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 2.94
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 2.94
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 2.94
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 2.92
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 2.91
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 2.91
An siRNA screen identifies CHD4 as a target for epigenetic therapy 2.88
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 2.85
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 2.85
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 2.84
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 2.84
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 2.82
CHCHD10 gene KO effect in iPSC drived motor neurons 2.77
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 2.75
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 2.75
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 2.7
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 2.69
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 2.66
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 2.66
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 2.64
Transcriptome of EBV-infected gastric cancer cell lines 2.63
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 2.62
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.57
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.57
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 2.55
CHCHD2 gene KO effect in iPSC drived motor neurons 2.55
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 2.51
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 2.5
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 2.49
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 2.49
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 2.49
The Genomic Landscape of Atypical Fibroxanthoma 2.49
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 2.48
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 2.44
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 2.41
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 2.34
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 2.34
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 2.31
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 2.27
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 2.25
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 2.23
MARS Seq data from human cortical organoids 2.21
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 2.2
RNA-seq of naive and primed ES cells (NHSM) 2.19
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 2.17
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 2.16
RNA sequencing of human mammary epithelial cells 2.15
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 2.13
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 2.13
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 2.13
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 2.12
Identification of expressed and conserved human non-coding RNAs 2.11
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 2.09
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 2.09
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 2.09
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 2.09
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 2.08
Human optic chiasm from healthy controls and multiple sclerosis patients 2.08
Multiple sclerosis and EAE 2.08
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 2.05
RNA sequencing of matched nephrectomy samples [RNA-seq] 2.05
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 2.05
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 2.05
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 2.04
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 2.02
Fbxo32 mediated gene expression program underlies EMT and metastasis 2.02
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 1.97
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 1.97
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 1.96
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 1.95
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 1.95
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 1.93
The age and genomic integrity of neurons after cortical stroke in humans 1.91
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 1.89
Glioblastoma stem cells infected by ZIKA virus 1.89
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 1.87
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 1.87
Depicting early human development and germ cell origin with porcine embryos 1.86
PNET animal model: new insights (II) 1.85
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 1.83
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 1.83
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 1.81
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.77
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 1.77
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 1.77
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 1.77
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 1.74
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 1.74
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 1.72
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 1.71
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 1.7
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 1.7
Epigenomic conservation of transposable element silencing 1.62
Epigenomic conservation of transposable element silencing [RNA-seq] 1.62
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 1.57
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 1.57
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 1.56
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 1.56
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 1.55
FGF2 regulation of gene expression in stable inducible Neurons 1.54
LINE-2 transposable elements are a source of functional human microRNAs and target sites 1.53
SLIGRL-induced gene expression changes in NHEK cells 1.5
Gene profiling of human adult and pediatric liver cancer cells 1.49
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 1.46
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 1.42
The circadian transcriptional landscape in primary human mammary epithelial cells 1.41
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 1.36
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 1.36
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 1.34
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 1.32
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.32
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 1.3
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 1.3
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 1.29
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 1.29
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 1.26
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 1.26
Identification of Atrial Fibrillation associated genes and functional non-coding variants 1.25
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 1.21
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.19
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 1.18
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 1.16
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 1.16
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 1.16
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.13
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 1.12
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 1.09
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 1.09
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 1.08
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 1.07
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 1.07
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 1.06
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 1.06
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 1.06
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 1.06
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 1.05
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 1.05
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 1.05
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 1.05
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 1.04
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 1.04
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 1.02
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 1.01
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 0.94
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.93
Transcriptomic analysis of frontal fibrosing alopecia 0.91
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.9
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.9
RNAseq in Alzheimer's Disease patients 0.89
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.88
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.85
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.84
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 0.83
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 0.82
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.77
Modeling Familial Cancer with iPSC Approaches 0.76
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.76
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 0.74
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 0.73
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.73
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.73
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.73
RNA seq analysis of human Fetal and adult derived Enterospheres 0.72
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 0.72
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.72
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 0.72
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.72
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.72
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.71
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 0.71
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.69
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 0.68
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 0.65
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.65
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.63
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 0.6
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 0.6
Patient-derived xenograft platform for metastatic melanoma 0.58
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 0.58
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 0.56
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.52
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.51
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 0.49
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 0.48
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 0.48
Identification of long noncoding RNAs regulated by p53 0.48
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.47
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 0.46
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.42
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.42
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.42
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.41
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 0.4
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 0.4
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.39
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 0.39
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.39
iPSC derived motor neuron cultures from C9ORF72 carriers 0.37
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.34
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 0.32
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 0.32
mRNA sequencing of oropharyngeal cancer cell lines 0.32
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.31
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 0.31
Global transcriptome analysis of WT versus HEB-/- hESCs 0.29
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 0.28
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 0.27
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 0.26
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 0.25
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.24
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 0.24
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 0.24
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 0.23
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.22
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.22
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 0.22
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.22
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 0.22
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.21
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.21
ML29755 RNA-seq data 0.21
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 0.21
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 0.2
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 0.2
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 0.19
The effect of insulin on mRNA transcription of human pluripotent stem cells 0.17
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 0.14
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 0.12
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.08
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 0.05
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.04
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation